<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        4-366-07
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2007
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ASACOL 500MG SUPPOSITORIES
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        MESALAZINE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        500
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Rectal use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Suppository
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        58.70
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="WULFING PHARMA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            WULFING PHARMA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 606]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ALHAYA MEDICAL CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            TILLOTTS
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A07EC02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Asacol is a medicine for topical treatment of inflammation affecting the rectum and colon lining. Asacol reduces inflammation in an acute episode of chronic inflammatory bowel disease and prevents relapses in the remission period. Asacol suppositories are used in chronic inflammatory bowel disease, i.e., for ulcerative colitis (chronic inflammatory disease of the large intestine), proctitis (inflammation of the rectum) and proctosigmoiditis (inflammation of the lowermost sections of the colon).</p><p>&nbsp;</p><p>Asacol suppositories are also used for painful inflammatory complications of piles. Asacol may only be used on a doctor&#39;s prescription.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>No dose recommendations for children and adolescents are available.</p><p>&nbsp;</p><p><strong>Do not take Asacol</strong></p><p>Do not use Asacol in the following cases:</p><p>Severe liver and kidney dysfunction, allergy to salicylates; hypersensitivity to mesalazine or any of the other ingredients; children under 2 years.</p><p>&nbsp;</p><p><strong>Warnings and precautions</strong></p><p>In particular, tell your doctor or pharmacist if you have kidney dysfunction.</p><p>&nbsp;</p><p>If you notice any unexplained bleeding, bruising, pinpoint bleeding in the skin, anaemia, persistent fever or sore throat, stop the treatment immediately and consult your doctor immediately, as your blood count might have changed. Your doctor will know what to do in such cases.</p><p>&nbsp;</p><p>If acute intolerance reactions should occur, such as cramps, abdominal pain, fever, severe headache or rash, stop the treatment immediately and contact your doctor.</p><p>&nbsp;</p><p>Talk to your doctor before using Asacol if you if you have ever developed a severe skin rash or skin peeling, blistering and/or mouth sores after using mesalazine.</p><p>Serious skin reactions including Stevens-Johnson syndrome, toxic epidermal necrolysis have been reported in association with mesalazine treatment. Stop using mesalazine and seek medical attention immediately if you notice any of the symptoms related to these serious skin reactions described in section 4.</p><p>&nbsp;</p><p>Caution is advised when Asacol is administered to patients with liver or kidney dysfunction and in patients with a history of hypersensitivity reactions affecting the heart (myocarditis and pericarditis), irrespective of their cause.</p><p>&nbsp;</p><p>Before and during treatment with Asacol, your doctor will consider whether you need regular examinations to check that your liver, kidneys, lungs and blood are normal. It is recommended that you keep all appointments for tests arranged by your doctor.</p><p>&nbsp;</p><p>Treatment should be started with caution if you have a stomach or intestinal ulcer or lung disease, especially asthma.</p><p>&nbsp;</p><p>Kidney stones may develop with use of mesalazine. Symptoms may include pain in sides of abdomen and blood in urine. Take care to drink sufficient amount of liquid during treatment with mesalazine.</p><p>&nbsp;</p><p><strong>Children</strong></p><p>The safety and effectiveness of Asacol suppositories has not been sufficiently studied in children and adolescents.</p><p>&nbsp;</p><p><strong>Other medicines and Asacol</strong></p><p>Tell your doctor or pharmacist if you are suffering from other illnesses, have any allergies or are taking or externally using other medicines (including those purchased without a prescription).</p><p>&nbsp;</p><p>There are known drug interactions with warfarin and phenprocoumon (anticoagulants), azathioprine (an immunosuppressant), as well as mercaptopurine and thioguanine (cytostatics).</p><p>&nbsp;</p><p>Mesalazine may produce red-brown urine discoloration after contact with sodium hypochlorite bleach in the toilet water. It concerns a chemical reaction between mesalazine and bleach and is harmless.</p><p>&nbsp;</p><p><strong>Pregnancy and breastfeeding?</strong></p><p>Asacol is excreted in human milk. During pregnancy and breast-feeding, Asacol should be used only after consultation with your doctor or pharmacist.</p><p><strong>&nbsp;</strong></p><p><strong>Driving and using machines</strong></p><p>Asacol has no or negligible influence on the ability to drive and use machines. However, if you are affected in anyway, do not drive or operate machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.</p><p><strong>&nbsp;</strong></p><p>Adults: For the treatment of chronic inflammatory bowel disease</p><p>a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In acute episodes, unless otherwise prescribed</p><p>Morning, noon and evening: insert 1 Asacol suppository (after a bowel movement).</p><p>&nbsp;</p><p>b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; For the prevention of relapse</p><p>As maintenance therapy after an acute episode has subsided, unless otherwise prescribed: insert 1 Asacol suppository morning and evening (after a bowel movement).</p><p>Long-term treatment with Asacol for the prevention of relapse should also be administered regularly and consistently during the remission period, so that the desired response will occur.</p><p>&nbsp;</p><p>c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In painful inflammatory complications of piles</p><p>Unless otherwise prescribed, during the acute episode, insert 1 Asacol suppository morning and evening (after a bowel movement). After the acute symptoms have subsided, Asacol suppositories should be used for at least another week.</p><p>&nbsp;</p><p>To date, the use and safety of Asacol in children and adolescents have not been investigated.</p><p>&nbsp;</p><p>Do not change the prescribed dose by yourself. If you think that the effect of the medicine is too weak or too strong, talk to your doctor or pharmacist.</p><p>&nbsp;</p><p>If you take more Asacol than you should</p><p>You should not take a higher dose than your doctor has prescribed for you. Contact your nearest hospital casualty department or a doctor for advice if you or anyone else has used too many suppositories. Take this leaflet, and any suppositories that you still have to show the doctor.</p><p>&nbsp;</p><p>If you forget to take Asacol</p><p>If you forget to take a suppository, take one as soon as you remember unless it is nearly time to take the next one. Do not take a double dose to make up for a forgotten dose.</p><p>&nbsp;</p><p>If you stop taking Asacol</p><p>Do not stop taking Asacol without talking to your doctor first even if you feel better. If you have any further questions on the use of this product, ask your doctor or pharmacist.</p><p>&nbsp;</p><p><strong>Taking Asacol with food and drink</strong></p><p>No special recommendations about administration of the suppositories.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p><strong>Stop taking this medicine at once and seek urgent medical advice immediately if you notice any of the following symptoms: </strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you get bruising (without injury), pinpoint bleeding or spots under the skin, anaemia (you feel tired, weak and turn pale, especially at the lips, nails and inside the eyelids), fever, sore throat or unusual bleeding (e.g., nosebleeds).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are unable to tolerate the suppositories and get cramps, acute abdominal pain, fever, severe headache or rash.</p><p>&nbsp;</p><p>The following frequencies are used for evaluating side effects:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Very common: in more than 1 in 10 patients treated.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common: in less than 1 in 10, but more than 1 in 100 patients treated.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Uncommon: in less than 1 in 100, but more than 1 in 1,000 patients treated.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rare: in less than 1 in 1,000, but more than 1 in 10,000 patients treated.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Very rare: in less than 1 in 10,000 patients treated.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Not known: cannot be estimated from the available data.</p><p>&nbsp;</p><p><strong>The following side effects can occur when taking Asacol: </strong></p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Very common</strong>: headache.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Common</strong>: dizziness, vomiting, abdominal pain, nausea, diarrhoea, indigestion, rash, joint pain, fever.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Uncommon</strong>: increased number of eosinophil granulocytes, feeling of pins and needles, tingling or numbness of the skin, bloating, hives, itching, muscle pain, chest pain.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Rare</strong>: inflammation of the heart muscle or pericardium (sac surrounding the heart), with symptoms such as chest pain or palpitations. Increased sensitivity of your skin to sun and ultraviolet light (photosensitivity).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Very rare</strong>: severe reduction in the number of all blood cells, which may cause weakness or bruising, or which promotes infection, a decrease in the number of blood cells, a reduction in the number of platelets with increased risk of bleeding, allergic reactions such as rash, drug-induced fever which subsides after discontinuation, immune system disorders, which may affect organs and joints, ulcerative colitis of the entire colon, numbness/tingling due to abnormal or damaged nerves, lung disease (scarring of the lung tissue, allergic reaction) associated with fluid accumulation in the lungs, pneumonia, inflammation of the pancreas (associated with pain in the upper abdomen and back, as well as nausea), increase in liver function tests, hepatitis (inflammation of the liver with flu-like symptoms and jaundice), hair loss, kidney disease (e.g. inflammation and scarring of the kidneys), kidney failure, which may be reversible upon early discontinuation of treatment, decrease in sperm production, which returns to normal after stopping the medicine.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Not known</strong>: lupus-like disease of the immune system with, for example: inflammation of the pericardium (sac surrounding the heart) or inflammation of both the pericardium and pleura (lining of the lungs), rash and/or joint pain, weight loss, laboratory test results outside the normal range, intolerance reactions including increased symptoms of the underlying disease, inflammation of the tissue layers (pleura) lining the lungs and chest wall, kidney stones and associated kidney pain.</p><p>&nbsp;</p><p>An unknown number of the above side effects are probably due more to the underlying, chronic inflammatory bowel disease rather than to treatment with Asacol. This is especially true for side effects of the gastrointestinal tract and joint pain.</p><p>If, during treatment with Asacol, you notice these or any other changes or discomfort, inform your doctor or pharmacist immediately.</p><p>&nbsp;</p><p>If you get any side effects that are not described here, you should tell your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Asacol suppositories should be stored in their original pack at a temperature not exceeding 25&deg;C and protected from the moisture and light.</p><p>This medicine must not be used only until the date printed as &ldquo;EXP&rdquo; on the pack.</p><p>Keep out of the sight and reach of children.</p><p>Further information can be obtained from your doctor or pharmacist, who have access to the detailed prescribing information.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away any medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>1 Asacol 500 mg suppository contains 500 mg mesalazine.</p><p>Excipients: hard fat.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                In pharmacies on presentation of a doctor’s prescription.
Asacol 500 mg Suppositories is offered in packs of 20. 


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>The marketing authorisation holder is:</strong></p><p>Tillotts Pharma AG, Baslerstrasse 15, 4310 Rheinfelden, Switzerland</p><p>&nbsp;</p><p><strong>The manufacturer is:</strong></p><p>Haupt Pharma W&uuml;lfing GmbH, D &ndash; 31028 Gronau, Germany.</p><p><br />&nbsp;</p><p><strong>To report any side effect(s):</strong></p><p><strong>&nbsp;</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The National Pharmacovigilance Centre (NPC)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Center: 19999</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa ;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa/</p><p><strong>&nbsp;</strong></p></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other GCC states: </strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Please contact the relevant competent authority</em></p><p>&nbsp;</p></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p><strong>Council of Arab Health Ministers,</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>THIS IS A MEDICAMENT</strong></p><p><strong>&nbsp;</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Medicaments is a product which affects your health and its consumption contrary to instructions is danger for you.</em></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Follow strictly the doctor&rsquo;s prescription, the method of use and the Instructions of the pharmacist who sold the medicament.</em></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>The doctor and pharmacist are the experts in medicines, their benefits and risks.</em></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Do not by yourself interrupt the period of treatment prescribed for you.</em></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Do not repeat the same prescription without consulting your doctor.</em></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Keep all medicaments out of reach of children.</em></p></td></tr></tbody></table><p>&nbsp;</p><p>Council of Arab Health Ministers</p><p>Union of Arab Pharmacists</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This patient information leaflet was last revised in November 2022.


            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">أساكول هو دواء للعلاج الموضعي للالتهاب الذي يصيب بطانة المستقيم والقولون. يخفف أساكول من الالتهاب في النوبات الحادة لمرض التهاب الأمعاء المزمن ويمنع الانتكاسات خلال مدة توقف النوبات. تستخدم تحاميل أساكول للمصابين بمرض التهاب الأمعاء المزمن، أي التهاب القولون التقرحي (مرض الالتهاب المزمن للأمعاء الغليظة)، والتهاب المستقيم، والتهاب المستقيم والسيني (التهاب الأجزاء السفلية من القولون).</p><p dir="RTL">&nbsp;كما تستخدم تحاميل أساكول أيضاً لعلاج المضاعفات الالتهابية المؤلمة للبواسير. وينبغي عدم استعمال أساكول إلا بوصفة من الطبيب.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">لا تتوفر توصيات حول الجرعة اللازمة للأطفال والمراهقين.</p><p dir="RTL">&nbsp;</p><p dir="RTL">موانع استخدام أساكول</p><p dir="RTL">لا تستخدم أساكول في الحالات التالية:</p><p dir="RTL">الإصابة بالاختلال الوظيفي الشديد للكبد والكلى، والحساسية تجاه الساليسيلات، وفرط الحساسية تجاه الميسالازين وأي من المكونات الأخرى؛ ولا تستخدمه على الأطفال دون سن العامين.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>توخى العناية الخاصة عند استعمال أساكول</strong></p><p dir="RTL">ينبغي عليك إعلام طبيبك أو الصيدلي خاصة إن كنت تعاني من اختلال وظيفي في الكلى.</p><p dir="RTL">في حال لاحظت أي حالات لا تفسير لها من نزيف أو تكدّم أو نزيف نقطي في البشرة أو أنيميا أو حمّى مستمرة أو التهاب حلق، أوقف العلاج واستشر طبيبك على الفور، فقد يكون تعداد دمّك قد تغيّر. طبيبك يعرف الأمور التي ينبغي القيام بها في مثل هذه الحالات.</p><p dir="RTL">في حال التعرض لردود فعل حادة ناجمة عن عدم تحمّل الدواء، مثل التشنجات أو ألم البطن أو الحمّى أو الصداع الشديد أو الطفح الجلدي، أوقف العلاج فوراً واستشر طبيبك.</p><p dir="RTL">&nbsp;</p><p dir="RTL">تحدث إلى طبيبك قبل استخدام أساكول إذا كنت قد عانيت في أي وقت مضى من طفح جلدي شديد أو تقشير جلدي و / أو تقرحات و / أو تقرحات في الفم بعد استخدام الميسالازين.</p><p dir="RTL">تم الإبلاغ عن تفاعلات جلدية خطيرة لمرضى متلازمة ستيفنز جونسون وانحلال البشرة النخري السمي بالاقتران مع العلاج بالميسالازين. توقف عن استخدام الميسالازين واطلب العناية الطبية فورًا إذا لاحظت أيًا من الأعراض المرتبطة بتفاعلات الجلد الخطيرة الموضحة في القسم 4.</p><p dir="RTL">&nbsp;</p><p dir="RTL">كما ينبغي توخي الحذر عند استعمال أساكول من قبل المرضى الذين لديهم اختلال في وظائف الكبد أو الكلى والمرضى الذين تعرضوا سابقاً لردود فعل ناجمة عن حساسية مفرطة تؤثر على القلب (التهاب العضلة القلبية والتهاب التأمور) بغض النظر عن سببها.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قبل العلاج بأساكول وخلاله، سيقرر الطبيب فيما إن كنت تحتاج لفحوصات دورية للتأكد من عمل كبدك وكليتيك ورئتين والدم بشكل طبيعي. ويُنصح بحضور جميع مواعيد الفحوصات التي يرتب طبيبك لإجرائها.</p><p dir="RTL">ينبغي بدء العلاج بحذر إذا كنت تعاني من تقرح في المعدة أو الأمعاء أو من مرض في الرئتين، وخاصة الربو.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد تتكون حصى الكلى مع استخدام ميسالازين. وقد تشمل الأعراض ألم في جانبي البطن ودم في البول. احرص على شرب كمية كافية من السوائل خلال علاجك بميسالازين.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الأطفال</strong></p><p dir="RTL">لم تتم دراسة مدى سلامة وفعالية تحاميل أساكول على الأطفال والمراهقين بشكل كافٍ.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التداخلات</strong><strong> </strong><strong>الدوائية</strong><strong> </strong><strong>من</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>الأساكول</strong><strong> </strong><strong>مع</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>أدوية</strong><strong> </strong><strong>أخرى</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>أعشاب</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>مكملات</strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تعاني من أمراض أخرى، أو إذا كنت تعاني من أي نوع من الحساسية أو إذا كنت تأخذ أي أدوية خارجية أخرى (بما في ذلك الأدوية التي اشتريتها بدون وصفة طبية).</p><p dir="RTL">&nbsp;</p><p dir="RTL">للدواء تفاعلات معروفة مع وارفارين وفينبروكومون (مضادات للتخثر)، وأزاثيوبرين (كابح مناعي)، بالإضافة إلى ميركابتوبورين وثيوجوانين (مثبطات لنمو الخلايا).</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يتسبب الميسالازين في تغير لون البول إلى اللون الأحمر البني بعد التلامس مع مبيض هيبوكلوريت الصوديوم في ماء المرحاض. يتعلق بتفاعل كيميائي بين الميسالازين والمبيض وهو غير ضار.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل والرضاعة</strong></p><p dir="RTL">يتم إفراز أساكول في حليب الثدي. لذا ينبغي عدم استعمال أساكول خلال الحمل أو الرضاعة إلا بعد استشارة طبيبك أو الصيدلي.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>القيادة واستعمال الآلات</strong></p><p dir="RTL">أساكول ليس له تأثير أو تأثير ضئيل على القدرة على القيادة واستخدام الآلات. ومع ذلك ، إذا تأثرت بأي شكل من الأشكال ، فلا تقم بالقيادة أو تشغيل الآلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">استعمل دوماً هذا الدواء تماماً حسب إرشادات طبيبك. استشر طبيبك أو الصيدلي إن كنت غير متأكد.</p><p dir="RTL">&nbsp;</p><p dir="RTL">البالغون: لعلاج مرض التهاب الأمعاء المزمن</p><p dir="RTL">&nbsp;</p><p dir="RTL">&zwnj;أ)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; خلال النوبات الحادة، إلا في حال وصف الطبيب لطريقة مختلفة للاستعمال</p><p dir="RTL">الصباح، والظهر والمساء: أدخل &nbsp;في الشرج تحميلة واحدة من أساكول&nbsp; 500 ملغ (بعد الإخراج).</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&zwnj;ب)&nbsp;&nbsp;&nbsp; لتجنب الانتكاس:</p><p dir="RTL">تستعمل التحاميل كعلاج مستمر بعد أن تخف شدة النوبة الحادة، إلا في حال وصف الطبيب لطريقة مختلفة للاستعمال: أدخل تحميلة واحدة من أساكول&nbsp; 500 ملغ في الصباح والمساء (بعد الإخراج).</p><p dir="RTL">ينبغي أن يستمر العلاج طويل الأمد بواسطة أساكول&nbsp; 500 ملغ لغرض تجنب الانتكاس بشكل منتظم وثابت حتى خلال فترة توقف النوبات من أجل تحقيق النتيجة المرغوبة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&zwnj;ج)&nbsp;&nbsp;&nbsp;&nbsp; في حال الإصابة بمضاعفات مؤلمة لالتهاب البواسير</p><p dir="RTL">خلال النوبة الحادة، أدخل تحميلة واحدة من أساكول&nbsp; 500 ملغ في الصباح والمساء (بعد الإخراج)، إلا في حال وصف الطبيب خلاف ذلك. وبعد أن تخف شدة الأعراض الحادة، ينبغي الاستمرار باستعمال تحاميل أساكول لأسبوع إضافي واحد على الأقل.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لم يتم بعد لغاية تاريخه التحقق من سلامة استعمال أساكول&nbsp; 500 ملغ من قبل الأطفال والمراهقين.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تغيّر الجرعة الموصوفة بنفسك. إذا كنت تعتقد بأن للدواء مفعول ضعيف جداً أو قوي جداً، استشر طبيبك أو الصيدلي.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>في حال تناولك لأساكول بكمية أكثر من اللازم</strong></p><p dir="RTL">ينبغي عليك عدم تناول جرعة أكبر من الجرعة التي وصفها لك طبيبك. اتصل بقسم الطوارئ الأقرب لك أو بالطبيب للحصول على النصيحة في حال استعملت أنت أو شخص آخر لعدد أكثر من اللازم من التحاميل. خذ هذه النشرة معك بالإضافة إلى أي تحاميل لا تزال بحوزتك لعرضها على الطبيب.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>في حال نسيانك لتناول أساكول</strong></p><p dir="RTL">في حال نسيانك لتناول إحدى التحاميل، تناول واحدة فور تذكرك، إلا إن كان وقت تناول التحميلة القادمة قد اقترب. لا تتناول جرعة مزدوجة للتعويض عن الجرعة المنسية.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>في حال توقفك عن تناول أساكول</strong></p><p dir="RTL">لا تتوقف عن تناول أساكول دون التحدث مع طبيبك أولاً حتى وإن كنت تشعر بتحسّن. إذا كانت لديك أسئلة إضافية حول تناول هذا المنتج، اسأل طبيبك أو الصيدلي.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>تناول أساكول مع الطعام والشراب</strong></p><p dir="RTL">لا توجد توصيات خاصة حول استعمال التحاميل.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كما هو الحال مع جميع الأدوية، قد يتسبب هذا الدواء ببعض الآثار الجانبية، ولكنها لا تصيب الجميع.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;<strong><u>توقف عن تناول أساكول واطلب النصيحة الطبية الفورية إذا لاحظت أيًا من الأعراض التالية</u></strong><strong><u>:</u></strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا أصبت بالتكدّم (دون إصابة) أو النزيف النقطي أو البقع أسفل الجلد أو الأنيميا (شعورك بالتعب والشحوب، خاصة عند الشفتين والأظافر والجهة الداخلية من الجفون) أو الحمّى أو التهاب الحلق أو نزيف غير اعتيادي (مثل نزيف الأنف).</p><p dir="RTL">&nbsp;</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا لم تستطع تحمّل التحاميل وتعرضت لتشنجات أو ألم معوي حاد أو حمّى أو صداع شديد أو طفح جلدي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">تستخدم نسب التكرار التالية لتقييم الآثار الجانبية:</p><p dir="RTL">&nbsp;</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الآثار الجانبية الشائعة جداً: يتعرض لها أكثر من شخص 1 من أصل كل 10 مرضى يتم علاجهم.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الآثار الجانبية الشائعة: يتعرض لها أقل من شخص 1 من أصل كل 10، ولكن أكثر من شخص 1 من أصل كل 100 مريض يتم علاجهم.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الآثار الجانبية غير الشائعة: يتعرض لها أقل من شخص 1 من أصل كل 100، ولكن أكثر من شخص 1 من أصل كل 1.000 مريض يتم علاجهم.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الآثار الجانبية النادرة: يتعرض لها أقل من شخص 1 من أصل كل 1.000، ولكن أكثر من شخص 1 من أصل كل 10.000 مريض يتم علاجهم.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الآثار الجانبية النادرة جداً: يتعرض لها أقل من شخص 1 من أصل كل 10.000 مريض يتم علاجهم.</p><p dir="RTL">الآثار الجانبية ذات التكرار غير المعروف: لا يمكن تقديرها من البيانات المتوفرة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>قد تحدث الآثار الجانبية التالية عند تناول أساكول:</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>الآثار الجانبية الشائعة جداً:</strong> الصداع.</p><p dir="RTL">&nbsp;</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>الآثار الجانبية الشائعة:</strong> الدُوار، التقيؤ، ألم المعدة، الغثيان، الإسهال، عسر الهضم، الطفح الجلدي، ألم المفاصل، الحمّى.</p><p dir="RTL">&nbsp;</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>الآثار الجانبية غير الشائعة:</strong> عدد زائد من الحبيبات اليوزينية، الشعور بالوخز، تنميل البشرة أو خدرانها، انتفاخ، شرى، حكّة، ألم عضلات، ألم صدر.&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>الآثار الجانبية النادرة:</strong> التهاب عضلة القلب أو التأمور (الكيس المحيط بالقلب)، مع أعراض مثل ألم في الصدر أو خفقان. حساسية زائدة لبشرتك من الشمس والأشعة فوق بنفسجية (الحساسية الضوئية).</p><p dir="RTL">&nbsp;</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>الآثار الجانبية النادرة جداً:</strong> انخفاض شديد في تعداد جميع خلايا الدم مما قد يتسبب بالضعف أو التكّدم أو يعزز العدوات، انخفاض تعداد خلايا الدم، انخفاض عدد الصفائح الدموية مع ازدياد خطر النزيف، ردود فعل تحسسية مثل الطفح الجلدي، حمّى ناجمة عن الدواء تخف بعد التوقف عن استخدامه، اضطرابات في الجهاز المناعي قد تؤثر على الأعضاء والمفاصل، التهاب القولون التقرحي في كامل القولون، خدران/تنميل بسبب تضرر الأعصاب أو اعتلالها، مرض الرئتين (تندّب نسيج الرئة، رد فعل تحسسي) يصاحبه تجمّع السوائل في الرئتين، التهاب رئوي، التهاب البنكرياس (يصاحبه ألم في البطن العلوي والظهر، بالإضافة إلى غثيان)، ارتفاع في قيم نتائج وظائف الكبد، التهاب الكبد (التهاب الكبد مع أعراض شبيهة بالأنفلونزا واليرقان)، فقدان الشعر، مرض الكلى (مثل التهاب وتندّب الكلى)، فشل كلوي قد يكون قابل للعكس في حال الإيقاف المُبكّر للعلاج، انخفاض إنتاج الحيوانات المنوية يعود لمعدلاته الطبيعية بعد إيقاف الدواء.&nbsp; &nbsp;&nbsp;&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>الآثار الجانبية غير المعروفة:</strong> مرض شبيه بالذئبة في الجهاز المناعي يصاحبه على سبيل المثال: التهاب التأمور (الكيس الذي يحيط بالقلب) أو التهاب كل من التأمور وغشاء الجنب (بطانة الرئتين)، طفح جلدي و/أو ألم مفاصل، فقدان الوزن، خروج نتائج الفحوصات المخبرية عن معدلاتها الطبيعية، ردود فعل ناجمة عن عدم التحمّل تشمل ازدياد أعراض المرض الكامن، التهاب طبقات الأنسجة (غشاء الجنب) التي تبطّن الرئتين وجدار الصدر. حصوات الكلى وما يصاحبها من آلام في الكلى</p><p dir="RTL">&nbsp;</p><p dir="RTL">من المُرجّح أن يكون عدد غير معروف من الآثار الجانبية المذكورة أعلاه ناجماً أكثر عن مرض التهاب الأمعاء المزمن والكامن وليس عن العلاج بأساكول. وينطبق هذا الأمر بشكل خاص على الآثار الجانبية التي تصيب الجهاز الهضمي وألم المفاصل.</p><p dir="RTL">في حال لاحظت هذه التغيرات أو أي تغيرات أخرى أو إزعاجات خلال تعالجك بأساكول، أخبر طبيبك أو الصيدلي على الفور.</p><p dir="RTL">&nbsp;</p><p dir="RTL">في حال إصابتك بأي آثار جانبية غير مذكورة هنا، ينبغي عليك إعلام طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يجب تخزين تحاميل أساكول في علبتها الأصلية بدرجة حرارة لا تتجاوز 25 درجة مئوية وفي مكان محمي من الرطوبة وأشعة الشمس المباشرة.</p><p dir="RTL">&nbsp;ينبغي عدم استخدام هذا الدواء بعد تاريخ انتهاء الصلاحية (&quot;EXP&quot;) المطبوع على العلبة.</p><p dir="RTL">يُحفظ بعيداً عن متناول الأطفال.</p><p dir="RTL">يمكنك الحصول على المزيد من المعلومات من طبيبك أو من الصيدلي حيث تتوفر لديهما المعلومات الشاملة حول وصف الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تتخلص من أية أدوية من خلال مياه الصرف الصحي أو برميها في نفايات المنزل. اسأل الصيدلي حول طريقة التخلص من الأدوية التي لم تعد تستعملها. ستساعد هذه الإجراءات في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">أساكول 500 ملغ تحتوي على:</p><p dir="RTL">ميسالازين 500 ملغ.</p><p dir="RTL">سِواغ: دهن صلب.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">في الصيدليات عند تقديم وصفة الطبيب.</p><p dir="RTL">تباع تحاميل أساكول 500 ملغ في علب تحتوي على 20 تحميلة</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>حامل تصريح التسويق هو:</strong></p><p dir="RTL">Tillotts Pharma AG, Baslerstrasse 15</p><p dir="RTL">4310 Rheinfelden</p><p dir="RTL">Switzerland</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الشركة المُصنّعة هي:</strong></p><p dir="RTL">Haupt Pharma W&uuml;lfing GmbH, D &ndash; 31028 Gronau, Germany</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>حامل تصريح التسويق هو:</strong></p><p dir="RTL">تيلوتس فارما إيه جي ، بازلرشتراسه 15 4310 راينفيلدن ، سويسرا</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الشركة المُصنّعة هي:</strong></p><p dir="RTL">هاوبت فارما وولفينج جي إم بي إتش، دي- 31028 جروناو، ألمانيا</p><p>&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>للإبلاغ عن أي آثار جانبية:</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong><em>المملكة العربية السعودية:</em></strong></p><p dir="RTL"><!--[if mso & !supportInlineShapes & supportFields]><span
style='mso-element:field-begin;mso-field-lock:yes'></span><span dir=LTR></span><span
dir=LTR></span><span dir=LTR><span dir=LTR></span><span dir=LTR></span><span
style='mso-spacerun:yes'> </span>SHAPE <span
style='mso-spacerun:yes'> </span>\* MERGEFORMAT <span style='mso-element:field-separator'></span></span><![endif]--></p><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><p>&nbsp;</p><p dir="RTL">المركز الوطني للتيقظ الدوائي:</p><p dir="RTL">مركز االتصال الموحد: 19999</p><p dir="RTL">البريد الإلكتروني npc.drug@sfda.gov.sa :</p><p dir="RTL">الموقع الإلكتروني https://ade.sfda.gov.sa :</p></td></tr></tbody></table><p><!--[if mso & !supportInlineShapes & supportFields]><span
dir=LTR><v:shape id="_x0000_i1026" type="#_x0000_t75" style='width:411.6pt;
 height:71.8pt'>
 <v:imagedata croptop="-65520f" cropbottom="65520f"/>
</v:shape><span style='mso-element:field-end'></span></span><![endif]--></p><p>&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong><em>دول الخليج العربي الأخرى:</em></strong></p><p dir="RTL"><!--[if mso & !supportInlineShapes & supportFields]><span
style='mso-element:field-begin;mso-field-lock:yes'></span><span dir=LTR></span><span
dir=LTR></span><span dir=LTR><span dir=LTR></span><span dir=LTR></span><span
style='mso-spacerun:yes'> </span>SHAPE <span
style='mso-spacerun:yes'> </span>\* MERGEFORMAT <span style='mso-element:field-separator'></span></span><![endif]--></p><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الرجاء الاتصال بالجهات الوطنية في كل دولة</p></td></tr></tbody></table><p><!--[if mso & !supportInlineShapes & supportFields]><span
dir=LTR><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:324.9pt;
 height:16.5pt'>
 <v:imagedata croptop="-65520f" cropbottom="65520f"/>
</v:shape><span style='mso-element:field-end'></span></span><![endif]--></p><p>&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">مجلس وزراء صحة العرب:</p><p dir="RTL">&nbsp;</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><strong>إن هذا الدواء</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الدواء مستحضر يؤثر على صحتك واستهلاكه خلافا للتعليمات يعرضك للخطر.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اتبع بدقة وصفة الطبيب وطريقة الاستعمال المنصوص عليها، وتعليمات الصيدلي الذي صرفها لك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطبيب والصيدلي هما الخبيران في الدواء، وفي نفعه وضرره.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تقطع مدة العلاج المحددة لك من تلقاء نفسك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تكرر صرف الدواء بدون استشارة الطبيب المختص.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تترك الأدوية في متناول الأطفال.</p><p dir="RTL">&nbsp;</p></td></tr></tbody></table><p dir="RTL">مجلس وزراء الصحة العرب</p><p dir="RTL">اتحاد الصيادلة العرب</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت مراجعة نشرة معلومات المريض هذه في نوفمبر 2022.


        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Asacol 500 mg suppositories.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each suppository contains: 500 mg mesalazine.
For a full list of excipients, see section 6.1.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Light grey-brown, torpedo-shaped suppositories
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>For acute treatment of ulcerative proctitis (up to 20 cm from the anus).</p><p>May also be used for acute treatment or maintenance of remission in ulcerative colitis in the region of the rectosigmoid or for painful inflammatory complications of haemorrhoids such as anusitis, cryptitis, anal papillitis and rhagades.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&middot;&nbsp;&nbsp;&nbsp; <strong>For ulcerative colitis (colitis, rectosigmoiditis and proctitis):</strong></p><p>Adults:</p><p><strong><em>Acute episode: </em></strong></p><p>1 Asacol suppository in the morning, at midday and in the evening.</p><p>Asacol suppositories may be administered in combination with Asacol gastro-resistant tablets.</p><p><strong><em>Maintenance of remission: </em></strong></p><p>During the remission phase, long-term treatment is indicated to prevent recurrence:</p><p>1 Asacol suppository in the morning and in the evening.</p><p>Long-term treatment with Asacol should also be carried out consistently for maintenance of remission.</p><p>&middot;&nbsp;&nbsp;&nbsp; <strong>For painful inflammatory complications of haemorrhoids</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; During the acute phase, 1 Asacol suppository in the morning and in the evening.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; After the acute symptoms have disappeared, the suppositories should be administered at least for 1 further week.</p><p>&nbsp;</p><p><strong>Elderly population</strong></p><p>Except in cases of severely impaired hepatic and renal function, the dosage stated for adults can be administered (see section 4.4 ). No studies have been performed with elderly patients.</p><p><strong>Paediatric population </strong></p><p>To date, its use and safety in children and adolescents under 18 years have not been sufficiently investigated.</p><p><strong>Mode of administration</strong></p><p>The suppositories are for rectal use and must not be swallowed.</p><p>The suppositories should be inserted deep into the anus after defaecation.</p><p>If one or several doses are omitted, the next dose should be taken as normal.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                - Hypersensitivity to mesalazine or to any of the excipient listed in section 6.1.
- Known allergy to salicylates.
- Severe liver impairment.
- Severe renal impairment (GFR < 30 mL/min/1.73m2).
- Children under 2 years.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Blood tests (differential blood count, liver function parameters such as ALT or AST; serum creatinine) and urinary status (dip sticks) should be determined prior to and during treatment, at the discretion of the treating physician. As a guideline, follow-up tests are recommended 14 days after commencement of treatment and then every 4 weeks for the following 12 weeks. If the findings are normal, follow-up tests should be carried out every three months. If additional signs appear, these tests should be performed immediately.</p><p><u>Renal impairment</u></p><p>Caution should be exercised in patients with raised blood urea or proteinuria. The possibility of mesalazine-induced nephrotoxicity must be considered in patients developing impairment of renal function during treatment.</p><p>Treatment with Asacol should be stopped immediately if there is evidence of renal impairment and patients should seek immediate medical advice.</p><p><u>Nephrolithiasis</u></p><p>Cases of nephrolithiasis have been reported with the use of mesalazine including stones with a 100% mesalazine content. It is recommended to ensure adequate fluid intake during treatment.</p><p>Mesalazine may produce red-brown urine discoloration after contact with sodium hypochlorite bleach (e.g. in toilets cleaned with sodium hypochlorite contained in certain bleaches).</p><p><u>Severe cutaneous adverse reactions</u></p><p>Severe cutaneous adverse reactions (SCARs), including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), have been reported in association with mesalazine treatment.</p><p>Mesalazine should be discontinued, at the first appearance of signs and symptoms of severe skin reactions, such as skin rash, mucosal lesions, or any other sign of hypersensitivity.</p><p><u>Blood dyscrasia</u></p><p>Serious blood dyscrasia has very rarely been reported. Asacol therapy should be stopped <u>immediately</u> there is a suspicion or evidence of blood dyscrasia (signs of unexplained bleeding, haematoma, purpura, anaemia, persistent fever or sore throat) and patients should seek immediate medical advice.</p><p><u>Hepatic impairment</u></p><p>There have been reports of increased liver enzyme levels in patients taking preparations containing mesalazine. Caution is recommended if Asacol is administered to patients with liver impairment.</p><p><u>Cardiac hypersensitivity reactions</u></p><p>Mesalazine-induced cardiac hypersensitivity reactions (myo- and pericarditis) have been reported rarely with Asacol. In case of known previous mesalazine-induced cardiac hypersensitivity Asacol must not be administered. Caution should be taken in patients with previous myo- or pericarditis of allergic background regardless of its origin.</p><p><u>Pulmonary disease</u></p><p>Patients with lung disease, especially asthma, should be monitored with particular care during treatment with Asacol.</p><p><u>Adverse drug reactions to Sulphasalazine</u></p><p>Patients with a history of adverse drug reactions to sulphasalazine, therapy should be kept under close medical supervision. Treatment must be stopped immediately if acute symptoms of intolerance occur such as abdominal cramps, acute abdominal pain, fever, severe headache and rash.</p><p><u>Gastric and duodenal ulcers</u></p><p>In case of existing gastric or duodenal ulcers treatment should begin with caution based on theoretical grounds.</p><p><u>Elderly population</u></p><p>Use in older people should be handled with caution and the product should only be prescribed to patients having a normal or non-severely impaired liver and renal function, see section 4.3.</p><p><u>Paediatric population</u></p><p>There is little experience and only limited documentation for an effect in children.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>No interaction studies have been performed.</em></p><p>There is weak evidence that mesalazine might decrease the anticoagulant effect of warfarin.</p><p>&nbsp;</p><p>There have been isolated reports of supposedly altered coagulation (INR values) after combined administration with coumarins (phenprocoumon, warfarin).</p><p>Mesalazine can increase the myelosuppressive effects of azathioprine, 6-mercaptopurine or thioguanine. Life-threatening infections can occur. Patients should be closely observed for signs of infection and myelosuppression. Blood counts, especially white blood cell, platelet and lymphocyte counts, should be monitored especially at the start of such combination therapy and at regular intervals (weekly).</p><p>If the white blood cell count is stable after 1 month, monthly blood tests for the next three months, followed by quarterly check-ups, appear to be adequate. Apart from interaction studies with purin antimetabolites in adults and children no other interaction studies have been performed in adults or children.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>There are no adequate data from the use of Asacol in pregnant women. However, on a limited number (627) of pregnant women exposed to mesalazine no negative effects were found with regard to pregnancy or foetal/neonatal health. No other relevant epidemiological data are currently available.</p><p>In one single case, after long-term use of a high mesalazine dose (2 - 4 g, orally) during pregnancy, renal failure in a neonate was reported. Animal studies with oral mesalazine administration do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/foetal development, parturition or postnatal development. Asacol should only be used during pregnancy when the expected benefit outweighs the potential risk.</p><p><u>Breastfeeding</u></p><p>Low concentrations of mesalazine and its N-acetyl metabolite have been detected in human breast milk. The clinical significance of this is not known. To date, there is only limited experience during breastfeeding in women. Hypersensitivity reactions such as infant diarrhoea cannot be excluded. Therefore, Asacol should only be used during breastfeeding when the expected benefit outweighs the potential risk. If the infant develops diarrhoea, breastfeeding should be discontinued.</p><p><u>Fertility</u></p><p>No effects on fertility have been observed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Asacol has no or negligible influence on the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em><em>Summary of safety profile</em></p><p>Organ specific adverse drug reactions affecting the heart, lungs, liver, kidneys, pancreas, skin and subcutaneous tissue have been reported.</p><p>Treatment must be stopped <u>immediately</u> if acute symptoms of intolerance occur, such as cramps, abdominal pain, fever, severe headache or rash.</p><p>Severe cutaneous adverse reactions (SCARs), including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), have been reported in association with mesalazine treatment (see &ldquo;4.4 Special warnings and precautions for use&rdquo;).</p><p><em>b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em><em>Tabulated summary of adverse reactions</em></p><p>Undesirable effects relevant for the labelling reported from four double-blind clinical studies and one open label clinical trial, from spontaneous reporting, the literature and the EU Mesalazine Core Safety Profile of 07 April 2011 is listed below. The frequency of some reactions cannot be reliably estimated due to the limitation of the reporting source.</p><p>&nbsp;</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0" style="width:98%"><thead><tr><td><p><strong>System Organ Class</strong></p></td><td style="vertical-align:top"><p><strong>Rare</strong></p><p><strong>(&ge; 1/10,000 to &lt; 1/1,000)</strong></p></td><td style="vertical-align:top"><p><strong>Very rare</strong></p><p><strong>(&lt; 1/10,000)</strong></p></td><td style="vertical-align:top"><p><strong>Frequency not known</strong></p></td></tr></thead><tbody><tr><td style="vertical-align:top"><p><strong>Blood and lymphatic system disorders</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Altered blood count (aplastic anaemia, agranulocytosis, pancytopenia, neutropenia, leukopenia, thrombocytopenia)</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Immune system disorders</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Hypersensitivity reactions, such as allergic exanthema, drug fever, lupus erythematosus syndrome, pancolitis</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Nervous system disorders</strong></p></td><td style="vertical-align:top"><p>Headache, Dizziness</p></td><td style="vertical-align:top"><p>Peripheral neuropathy</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Cardiac disorders</strong></p></td><td style="vertical-align:top"><p>Myocarditis, Pericarditis</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Respiratory, thoracic and mediastinal disorders</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Allergic and fibrotic lung reactions (including dyspnoea, cough, bronchospasm, alveolitis, pulmonary eosinophilia, lung infiltration, pneumonitis),.</p></td><td style="vertical-align:top"><p>Pleuritis</p></td></tr><tr><td style="vertical-align:top"><p><strong>Gastrointestinal disorders</strong></p></td><td style="vertical-align:top"><p>abdominal pain, diarrhoea, flatulence, nausea, vomiting.</p></td><td style="vertical-align:top"><p>Acute pancreatitis</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Hepatobiliary disorders</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Changes in liver function parameters (increase in transaminases and cholestasis parameters), hepatitis, cholestatic hepatitis.</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Skin and subcutaneous tissue disorders</strong></p></td><td style="vertical-align:top"><p>Photosensitivity*</p><p>*see section c</p></td><td style="vertical-align:top"><p>Alopecia</p></td><td style="vertical-align:top"><p>Drug reaction with eosinophilia and systemic symptoms (DRESS), Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN)</p></td></tr><tr><td style="vertical-align:top"><p><strong>Musculoskeletal, connective tissue and bone disorders</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>myalgia, arthralgia.</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Renal and urinary disorders</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>impairment of renal function, including acute and chronic interstitial nephritis and renal insufficiency.</p></td><td style="vertical-align:top"><p>Nephrolithiasis**</p></td></tr><tr><td style="vertical-align:top"><p><strong>Reproductive system and breast disorders</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Oligospermia (reversible)</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>General disorders and administration site conditions</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Intolerance to mesalazine with C-reactive protein increased and/or exacerbation of symptoms of underlying disease, local reaction</p></td></tr></tbody></table><p>**See section 4.4 for further information</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><em>c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em><em>Description of selected adverse reactions</em></p><p>An unknown number of the above undesirable effects are probably related to the underlying IBD rather than Asacol/mesalazine medication. This holds true especially for gastrointestinal undesirable effects.</p><p>To avoid a blood dyscrasia resulting from developing bone marrow depression, patients should be monitored with care, see section 4.4.</p><p>Under co-administration of mesalazine with immunosuppressive drugs, such as azathioprine, 6-MP or thioguanine life threatening infection can occur, see section 4.5.</p><p><u>Photosensitivity</u></p><p>More severe reactions are reported in patients with pre-existing skin conditions such as atopic dermatitis and atopic eczema.</p><p><em>d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em><em>Paediatric population</em></p><p>There is only limited safety experience with the use of Asacol suppositories in the paediatric population. It is expected that the target organs of possible adverse reactions in the paediatric population are the same as for adults (heart, lungs, liver, kidneys, pancreas, skin and subcutaneous tissue.</p><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the following route:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong><em>Saudi Arabia</em></strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>The National Pharmacovigilance Centre (NPC)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Center: 19999</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Websitehttps://ade.sfda.gov.sa/</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong><em>Other GCC States</em></strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:576px"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are little data on overdose (e.g. intended suicide with a high oral dose of mesalazine), which do not indicate any renal or hepatic toxicity. There is no specific antidote and treatment is symptomatic and supportive.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Intestinal anti-inflammatory agents; ATC Code:A07EC02</p><p><strong>&nbsp;</strong></p><p><u>Mechanism of action</u></p><p>Asacol contains mesalazine, also known as5-aminosalicylic acid, which has anti-inflammatory effect through a mechanism that has not yet been fully clarified. Mesalazine has been shown to inhibit LTB4-stimulated migration of intestinal macrophages and thus may reduce intestinal inflammation by restricting migration of macrophages to inflamed areas. The production of pro-inflammatory leukotrienes (LTB4 and 5-HETE) in macrophages of the intestinal wall is inhibited. Under trial conditions cyclo-oxygenase and thus, the release of thromboxane B2 and prostaglandin E2 were inhibited, but the clinical relevance of this effects is not known. Mesalazine has been shown to activate PPAR-&gamma; receptors which counteract nuclear activation of intestinal inflammatory responses.</p><p><u>Pharmacodynamic effects</u></p><p>Under trial conditions mesalazine inhibited the cyclooxygenase and thus, the release of thromboxane B2 and prostaglandin E2, but the clinical meaning of this effect is still unclear. Mesalazine inhibits the formation of platelet activating factor (PAF). Mesalazine is also an antioxidant; it has been shown to decrease formation of reactive oxygen products and to capture free radicals.</p><p>Epidemiological data indicate that continued long-term mesalazine maintenance treatment may reduce the risk of colon cancer.</p><p><u>Clinical efficacy and safety</u></p><p>The acute treatment of ulcerative colitis was investigated in 529 patients with mild to moderately severe symptoms. Of six controlled studies two were placebo-controlled, four studies were reference-controlled or were used as dose finding studies. Duration of treatment varied between four and six weeks. Sigmoidoscopy was used to confirm diagnosis of the disease in the patients. Response to treatment was monitored by means of clinical investigations, self-control by the patients and clinical findings (sigmoidoscopy results) on a daily basis or at intervals of several weeks. Both placebo-controlled studies produced a statistically significant result in favour of mesalazine.</p><p>Maintenance of remission in ulcerative colitis was investigated in 503 patients. Of four controlled studies one was placebo-controlled and three reference-controlled. Duration of treatment varied between four and eleven months. The endpoint of the study was occurrence of a relapse on the evidence of sigmoidoscopy. The placebo-controlled study achieved a statistically significant result in favour of mesalazine.</p><p>The effect of mesalazine administered via the rectal route (Asacol suppositories) was tested in four double-blind studies in a total of 318 patients. Three studies investigated efficacy in the acute treatment of mild to moderately severe proctitis and proctosigmoiditis; two of the studies were placebo-controlled and one reference-controlled. Treatment lasted for four weeks. Both placebo-controlled studies produced a statistically significant result in favour of mesalazine. The fourth controlled study investigated the effect of a one year maintenance of remission. A significantly superior result was found for 0.5 g and 1 g mesalazine compared with placebo.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption</u></p><p>Only a proportion of mesalazine contained in the suppositories is absorbed and available to the systemic circulation. The mode of action of mesalazine is local rather than systemic. After a single dose of Asacol 500mg suppositories in healthy volunteers the mean C<sub>max</sub> and T<sub>max</sub> were 211 ng/mL and 2.0 hours for mesalazine and 443 ng/mL and 3.0 hours for N-acetyl mesalazine, respectively. About 43% of mesalazine and about 78% of N-acetyl mesalazine are bound to plasma proteins.</p><p><u>Distribution</u></p><p>Low concentrations of mesalazine and its N-acetyl metabolite have been detected in human breast milk. The clinical significance of this has not been determined.</p><p><u>Biotransformation</u></p><p>Mesalazine is metabolised both by the intestinal mucosa and the liver to the inactive metabolite N-acetyl mesalazine.</p><p><u>Elimination</u></p><p>The elimination of mesalazine is essentially faecal and urinary in the form of mesalazine and its N-acetyl metabolite. Mesalazine and the main metabolite N-acetyl mesalazine were reported to have biological half-lives of 4.97 hours and 8.32 hours, respectively, following the use of Asacol 500 mg Suppositories in healthy volunteers.</p><p><u>Linearity/non-linearity</u></p><p>No specific studies have been performed.</p><p><u>Pharmacokinetic/pharmacodynamic relationship(s)</u></p><p>No specific studies have been performed.</p><p><u>Kinetics in specific patient groups:</u></p><p>Kinetics in specific patient groups (e.g. in hepatic and renal insufficiency, genetic polymorphisms) has not been investigated.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No mutagenicity or clastogenic activity was found for mesalazine in the Ames test and no carcinogenicity in animal trials. In a study on bone marrow in mice, no micronucleus induction was demonstrated. In human lymphocytes no micronucleus induction or sister chromatid exchange was demonstrated for the primary metabolite N-acetyl-mesalazine. In studies on rats (360 mg/kg) or rabbits (480 mg/kg) no indications of an increased teratogenic risk were found. Mesalazine did not affect fertility in rats of either sex. The results of reproduction studies in female animal models did not indicate any negative effects on fertility, gestation, labour, parturition, lactation or viability.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hard fat</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 Years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Asacol suppositories should be stored in their original pack at a temperature not exceeding 25&deg; C and protected from moisture and direct sunlight.</p><p>Keep out of the sight and reach of children.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Asacol 500 mg suppositories are enclosed inside heat-sealed, non-toxic PVC/PE cavities, in strips of five suppositories and then packed in cardboard cartons.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements. Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Tillotts Pharma AG
Baslerstrasse 15
4310 Rheinfelden
Switzerland
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                November 2022
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>